AMPH — Amphastar Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $1.11bn
- $1.48bn
- $731.97m
- 76
- 90
- 57
- 88
Annual cashflow statement for Amphastar Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.1 | 63.3 | 91.4 | 138 | 160 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 25.7 | 10.7 | 21.2 | 44.7 | 33.3 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 9.13 | -1.92 | -32.2 | -24.2 | -14.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | 57.3 | 98 | 89.2 | 184 | 213 |
| Capital Expenditures | -33.9 | -27.5 | -24 | -38.2 | -41 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.56 | -1.22 | -8.74 | -611 | -83.9 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -36.4 | -28.7 | -32.8 | -649 | -125 |
| Financing Cash Flow Items | -0.106 | -56.2 | -0.407 | -25.1 | -0.816 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2.25 | -37 | -26.4 | 454 | -81 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19 | 32.1 | 29.7 | -11.8 | 7.31 |